NRC Health Q2 revenue $35M, EPS $0.26; amends credit; acquires NOBL Health

NRC HEALTH

2024-Q2 EPS reported $0.52 revenue$70,334,000

Q2 revenue ~$35M vs ~$36M YoY; diluted EPS $0.26 vs $0.29 YoY; TRCV $138M at June 30.
Credit agreement amended: maturity extended to May 2027; term loans bear SOFR+2.35% with 10-year amort.
Acquired NOBL Health on July 15 for ~$6M cash + up to $1M earnout; NOBL had ~$2M TRCV.
Board declared $0.12/share quarterly dividend, payable Oct 11, record Sep 27.
~1.1M shares remain under repurchase plan; no buybacks in Q2 pending amendment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.